Practice of HPV Vaccine and Associated Factors among School Girls in Melaka, Malaysia |
Al-Naggar, Redhwan Ahmed
(Community Medicine Department, International Medical School, Management and Science University)
Bobryshev, Yuri V. (Faculty of Medicine, School of Medical Sciences, University of New South Wales) Al-Jashamy, Karim (SEGi) Al-Musli, Mahfoudh (Pharmacology Department, International Medical School, Management and Science University) |
1 | Adams M, Jasani B, Fiander A (2007). Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening. Vaccine, 25, 3007-13. DOI |
2 | Agius PA, Pitts MK, Smith AM, Mitchell A (2010). Human papillomavirus and cervical cancer: Gardasil vaccination status and knowledge amongst a nationally representative sample of Australian secondary school students. Vaccine, 28, 4416-22. DOI |
3 | Al-Dubai SA, Alshagga MA, Al-Naggar RA, et al (2010). Knowledge, attitudes and barriers for human papilloma virus (HPV) vaccines among Malaysian women. Asian Pac J Cancer Prev, 11, 887-92. |
4 | Allen JD, Othus MK, Shelton RC, et al (2010). Parental decision making about the HPV vaccine. Cancer Epidemiol Biomarkers Prev, 19, 2187-98. DOI |
5 | Al-Naggar RA (2012). Acceptance and Associated factors of HPV Vaccination among Young Male Malaysians. J Community Med Health Edu (in press). |
6 | Al-Naggar RA, Bobryshev YV (2011). Practice towards Human Papillomavirus Vaccine among Malaysian Women: A survey of the General Population. Asian Pac J Cancer Prev, 12, 2045-9. |
7 | Al-Naggar RA, Karim Al-Jashamy K, Chen R (2010) Perceptions and Opinions towards Human Papilloma Virus Vaccine among Young Women. Asian Pac J Cancer Prev, 11, 1515-9. |
8 | Ault KA (2007). Effect of prophylactic human papillomavirus L1 virus-likeparticle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. Lancet, 369, 1861-8. DOI ScienceOn |
9 | Benard VB, Johnson CJ, Thompson TD, et al (2008). Examining the association between socioeconomic status and potential human papillomavirus-associated cancers. Cancer, 113, 2910-8. DOI |
10 | Bigham M, Remple VP, Pielak K, et al (2006). Uptake and behavioural and attitudinal determinants of immunization in an expanded routine infant hepatitis B vaccination program in British Columbia. Can J Public Health, 97, 90-5. |
11 | Bosch FX, de Sanjose S (2003). Chapter 1: human papillomavirus and cervical cancer—burden and assessment of causality. J Natl Cancer Inst Monogr, 31, 3-13. |
12 | Brewer NT, Fazekas KI (2007). Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med, 45, 107-14. DOI |
13 | Brewer NT, Gottlieb SL, Reiter PL, et al (2011). Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis, 38, 197-204. DOI |
14 | Bynum SA, Brandt HM, Patricia A, et al (2011). Working to close the gap: Identifying predictors of HPV vaccine uptake among young African American women. J Health Care Poor Underserv, 22, 549-61. DOI |
15 | Caskey R, Lindau ST, Alexander GC (2009). Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Health, 45, 453-62. DOI |
16 | Centers for Disease (2010). Control and Prevention. National, state, and local area vaccination coverage among adolescents aged 13-17 years—United States, 2009. MMWR Morbidity & Mortality Weekly Report, 59, 1018-23. |
17 | Chao C, Velicer C, Slezak JM, Jacobsen SJ (2010). Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol, 171, 357-67. DOI |
18 | Constantine NA, Jerman P (2007). Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health, 40, 108-15. DOI |
19 | Cook RL, Zhang J, Mullins J, et al (2010) Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in Medicaid. J Adolesc Health, 47, 596 -9. DOI |
20 | Daley MF, Liddon N, Crane LA, et al (2006). A National Survey of Pediatrician Knowledge and Attitudes Regarding Human Papillomavirus Vaccination. Pediatrics, 118, 2280-9. DOI |
21 | Davis K, Dickman ED, Ferris D, Dias JK (2004). Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis, 8, 188-94. DOI |
22 | Dempsey A, Cohn L, Dalton V, Ruffin M (2010). Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system. Vaccine, 28, 989-95. DOI |
23 | Dunne EF, Unger ER, Sternberg M, et al (2007). Prevalence of HPV infection among females in the United States. JAMA, 297, 813-9. DOI ScienceOn |
24 | Ferlay J, Bray F, Pisani P, Parkin D Globocan (2004). Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base, 5 version 2.0 IARC Press, Lyon. |
25 | Garland SM, Hernandez-Avila M, Wheeler CM, et al (2007). Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med, 356,1928-43. DOI ScienceOn |
26 | Gerend MA, Weibley E, Bland H (2009). Parental response to human papillomavirus vaccine availability: uptake and intentions. J Adolesc Health, 45, 528-31. DOI |
27 | Greer CE, Wheeler CM, Ladner MB, et al (1995). Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J Clin Microbiol, 33, 2058-63. |
28 | Jain N, Euler GL, Shefer A, et al (2009). Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult. Prev Med, 48, 426-31. DOI |
29 | Kahn JA, Zimet GD, Bernstein DI, et al (2005). Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. J Adolesc Health, 37, 502-10. DOI ScienceOn |
30 | Kahn JA, Rosenthal SL, Hamann T, et al (2003). Attitudes about human papillomavirus vaccine in young women. Int J STD AIDS, 14, 300-6. DOI |
31 | Kim YT (2009). Current status of cervical cancer and HPV infection in Korea. J Gynecol Oncol, 20, 1Y7. DOI |
32 | Kitchener HC, Almonte M, Wheeler P, el al (2006). HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial. Br J Cancer, 95, 56-61. DOI |
33 | Lee GM, Santoli JM, Hannan C, et al (2007). Gaps in vaccine fınancing for underinsured children in the U.S. JAMA, 298, 638-43. DOI |
34 | Lenehan JG, Leonard KC, Nandra S, et al (2008). Women's knowledge, attitudes, and intentions concerning human papillomavirus vaccination: findings of a waiting room survey of obstetrics gynaecology outpatients. J Obstet Gynaecol Canada, 30, 489-99. DOI |
35 | Lim GCC, Halimah Y (2004). Second report of the national cancer registry. Cancer. Incidence in malaysia 2003. Kuala lumpur: national cancer registry. |
36 | Lyn-Cook R, Halm EA, Wisnivesky J P (2007). Determinants of adherence to influenza vaccination among inner-city adults with persistent asthma. Primary Care Respiratory J, 16, 229-35. DOI |
37 | Madhivanan P, Krupp K, Yashodha MN, et al (2009). Attitudes toward HPV vaccination among parents of adolescent girls in Mysore, India. Vaccine, 27, 5203-8. DOI |
38 | National, state, and local area vaccination coverage among adolescents aged 13-17 years—United States, 2008. MMWR Morb Mortal Wkly Rep, 58, 997-1001. |
39 | Mathur MB, Mathur VS, Reichling DB (2010). Participation in the decision to become vaccinated against human papillomavirus by California High School girls and the predictors of vaccine status. J Pediatric Health Care, 24, 14-24. DOI |
40 | McLaughlin CG, Wyszewianski L (2002). Access to care: remembering old lessons. Health Serv Res, 6, 1441-3. |
41 | National, state, and local area vaccination coverage among adolescents aged 13-17 years—United States, 2009. MMWR Morb Mortal Wkly Rep, 59, 1018-23. |
42 | Nelson A (2002). Unequal treatment: Confronting racial and ethnic disparities in health care. J Natl Med Assoc, 94, 666-8. |
43 | Neubrand TPL, Breitkopf CR, Rupp R, Breitkopf D, Rosenthal SL (2009). Factors associated with completion of the human papillomavirus vaccine series. Clin Pediatr, 48, 966 -9. DOI |
44 | Niccolai LM, Mehta NR , Hadler JH (2011). Racial/Ethnic and Poverty Disparities in Human Papillomavirus Vaccination Completion. Am J Prev Med (in press). |
45 | Ogilvie G, Anderson M, Marra F, et al (2010). A populationbased evaluation of a publicly funded, school based HPV vaccine program in British Columbia, Canada: parental factors 580 associated with HPV vaccine receipt. PLoS Medicine, 7, 5. |
46 | Paavonen J, Jenkins D, Bosch FX, et al (2007). Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet, 369, 2161-70. DOI ScienceOn |
47 | Riedesel JM, Rosenthal SL, Zimet GD, et al (2005). Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol, 18, 391-8. DOI |
48 | Pruitt SL, Schootman M (2010). Geographic disparity, area poverty, and human papillomavirus vaccination. Am J Prev Med, 38, 525-33. DOI |
49 | Reiter PL, Cates JR, McRee AL, et al (2010). Statewide HPV vaccine initiation among adolescent females in North Carolina. Sex Transm Dis, 37, 549-56. DOI |
50 | Richardson H, Kelsall G, Tellier P, et al (2003). The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev, 12, 485-90. |
51 | Roberts SA, Brabin L, Stretch R, et al (2011). Human papillomavirus vaccination and social inequality: results from a prospective cohort study. Epidemiol Infect, 139, 400-5. DOI |
52 | Rosenthal SL, Rupp R, Zimet GD, et al (2008). Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health, 43, 239-45. DOI |
53 | Sauvageau C, Bernard D, Vladimir G, et al (2007). Human Papilloma Virus vaccine and cervical cancer screening acceptability among adults in Quebec. BMC Public Hlth, 7, 304. DOI |
54 | Seo K, Oh JK, Shin H (2008). Efficacy of human papillomavirus vaccines as an anticancer vaccine. J Korean Soc Matern Child Health, 12, 1-7. |
55 | Shahrabani S, Benzion U, Yom Din G (2009). Factors affecting nurses' decision to get the flu vaccine. Eur J Health Econ, 10, 227-31. DOI |
56 | Syrjänen S, Shabalova I, Petrovichev N, et al (2005). Cohort Study Group Age-specific incidence and clearance of highrisk human papillomavirus infections in women in the former Soviet Union. Int J STD AIDS, 16, 217-23. DOI |
57 | Smith LM, Brassard P, Kwong JC, et al (2011). Factors associated with initiation and completion of the quadrivalent human papillomavirus vaccine series in an ontario cohort of grade 8 girls. BMC Public Health, 11, 645. DOI |
58 | Social Statistics Bulletin, Malaysia (2005). Kuala Lumpur: Department of Statistics, Malaysia. |
59 | Songthap A, Pitisuttithum P, Kaewkungwal J, et al (2009). Knowledge, attitudes, and acceptability of a human papillomavirus vaccine among healthcare providers. Southeast Asian J Trop Med Public Health, 40, 1048-56. |
60 | Villa LL, Costa RLR, Petta CA, et al (2005). Prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) L1 virus-like particle vaccine in young women: a randomized double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol, 6, 271-8. DOI ScienceOn |
61 | Walboomers JM, Jacobs MV, Manos MM, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9. DOI ScienceOn |
62 | Widdice LE, Bernstein DL, Leonard AC, Marsolo KA, Kahn JA (2011). Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics, 127, 77-84. DOI |
63 | Wong CA, Berkowitz Z, Dorell CG, et al (2008). Human Papillomavirus Vaccine Uptake Among 9- to 17-Year-Old Girls. Cancer, 117, 5612-20. |
64 | Wong LP, Wong YL, Low WY, et al (2009). Knowledge and awareness of cervical cancer and screening among Malaysian women who have never had a Pap smear: a qualitative study. Singapore Med J, 50, 49-53. |
65 | Zimet GD, Weiss TW, Rosenthal SL, et al (2010). Reasons for non-vaccination against HPV and future vaccination intentions among 19-26 year-old women. BMC Women's Health, 10, 27. DOI |
66 | Yeganeh N, Curtis D, Kuo A (2010). Factors influencing HPV vaccination status in a Latino population; and parental attitudes towards vaccine mandates. Vaccine, 28, 4186-91. DOI ScienceOn |
67 | Zimet GD, Liddon N, Rosenthal SL, Lazcano-Ponce E, Allen B (2006). Chapter 24: psychosocial aspects of vaccine acceptability. Vaccine, 24, 201-9. DOI |